List of Exostar Secure Access Manager Customers
Herndon, 20171, VA,
United States
Since 2010, our global team of researchers has been studying Exostar Secure Access Manager customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Exostar Secure Access Manager for Single Sign-On (SSO) from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Exostar Secure Access Manager for Single Sign-On (SSO) include: Pfizer, a United States based Life Sciences organisation with 81000 employees and revenues of $63.63 billion, Amgen, a United States based Life Sciences organisation with 28000 employees and revenues of $33.42 billion, Cliniops, a United States based Life Sciences organisation with 27 employees and revenues of $5.0 million and many others.
Contact us if you need a completed and verified list of companies using Exostar Secure Access Manager, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Exostar Secure Access Manager customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Amgen | Life Sciences | 28000 | $33.4B | United States | Exostar | Exostar Secure Access Manager | Single Sign-On (SSO) | 2015 | n/a |
In 2015, Amgen deployed Exostar Secure Access Manager to provide Single Sign-On (SSO) and identity federation for its research and clinical collaboration environment. The implementation is documented by Exostar as supporting Amgen's life sciences collaboration use cases across the United States and globally, with an emphasis on partner access and federated identity management.
Exostar Secure Access Manager was configured to deliver core SAM capabilities, including single sign-on, identity federation, centralized access control, and partner onboarding workflows consistent with the Single Sign-On (SSO) category. Configuration work focused on assertion handling, role based access mapping, and centralized policy enforcement to standardize authentication across collaboration systems.
The deployment connected Amgen collaboration portals and external partner identity providers through Exostar's federation model to enable cross-organization access for research and clinical partners. Operational coverage explicitly included research and clinical collaboration activities across US and global partner networks, aligning authentication flows for multi‑organization projects.
Governance centered on standardized onboarding processes for external partners and centralized authentication policy management, reflecting Exostar's stated benefits of improved security and partner onboarding. The Amgen implementation of Exostar Secure Access Manager positions Single Sign-On (SSO) as the primary control plane for external identity federation and partner access in research and clinical collaboration.
|
 |
Cliniops | Life Sciences | 27 | $5M | United States | Exostar | Exostar Secure Access Manager | Single Sign-On (SSO) | 2022 | n/a |
In 2022, CliniOps integrated its clinical trial platform with Exostar Secure Access Manager to deliver a Single Sign-On (SSO) experience for investigative sites across trial systems. The Exostar Secure Access Manager integration centralizes authentication on the CliniOps platform, addressing login fatigue and improving site efficiency for clinical operations across multiple countries.
The implementation focused on standard Single Sign-On (SSO) capabilities, including centralized authentication, federated identity, single session management, role based access control and user provisioning workflows common to SSO deployments. CliniOps configured Exostar Secure Access Manager to align identity and access profiles with site roles and trial permissions, enabling consistent access policies across connected trial applications.
Integration work connected the CliniOps clinical trial platform with Exostar Secure Access Manager to streamline site authentication flows across third party trial systems used by investigative sites, and the initiative was publicly announced in September 2022. Operational coverage targets life sciences and clinical trial workflows across multiple countries, with the primary business functions impacted being clinical operations and site management.
Deployment governance emphasized centralized access control and standardized onboarding processes for investigative sites, with configuration and policy enforcement managed through identity and access management governance rather than bespoke credentialing. Outcomes stated in the announcement include reduced login fatigue for site users and improved site efficiency for clinical operations.
|
 |
Pfizer | Life Sciences | 81000 | $63.6B | United States | Exostar | Exostar Secure Access Manager | Single Sign-On (SSO) | 2015 | n/a |
In 2015, Pfizer implemented Exostar Secure Access Manager to provide Single Sign-On (SSO) for partner and clinical applications. The deployment supported external collaboration and R&D workflows across Pfizer's global operations, and is documented on Exostar's Life Sciences customer pages as a life sciences use case.
Exostar Secure Access Manager centralizes federated authentication and external user access for partner ecosystems, aligning with Single Sign-On (SSO) category capabilities such as centralized access governance, streamlined onboarding, and session continuity across partner and clinical systems. The implementation focuses on integrations with partner and clinical applications to unify access across organizational boundaries, with operational coverage concentrated on R&D and external collaboration teams. The rollout established a consistent access control surface for Pfizer's partner-facing systems and is described as enhancing security and user experience for external collaborators.
|
Buyer Intent: Companies Evaluating Exostar Secure Access Manager
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||